A detailed description of patient's blood morphology throughout the treatment process and additional key symptoms observed in the process
| Days of hospitalization | ||||||
|---|---|---|---|---|---|---|
| 7 | 9 | 10 | 11 | 13 | 14 | |
| Parameter value in PB | ||||||
| Leukocytes [103 /μl] | 9.77 | 7.47 | 6.03 | 9.38 | 5.9 | 6.27 |
| Neutrophils [%] | 82.7 | 62.1 | 84.1 | 79 | 57.4 | 62.4 |
| Eosinophils [%] | 1.6 | 12 | 2 | 1.5 | 13.4 | 8.8 |
| Basophils [%] | 0.2 | 0.8 | 0 | 0.2 | 1 | 0.6 |
| Lymphocytes [%] | 12 | 15.3 | 9.1 | 15.4 | 21.5 | 21.5 |
| Monocytes [%] | 3.4 | 9.8 | 4.8 | 3.9 | 9.7 | 6.7 |
| Erythrocytes [106 /μl] | 4 | 3.5 | 3 | 3.2 | 3.5 | 3.6 |
| Hemoglobin [g/dl] | 11.2 | 10.4 | 8.5 | 9.3 | 10.1 | 10.3 |
| Hematocrit [%] | 34.3 | 31.4 | 25.7 | 27.3 | 30.1 | 29.8 |
| MCV [10−15 /μl] | 86.4 | 89 | 85.7 | 84.5 | 87 | 83.5 |
| MCH [pg/cell] | 28.2 | 29.5 | 28.3 | 28.8 | 29.2 | 28.9 |
| MCHC [g/dl] | 32.7 | 33.1 | 33.1 | 34.1 | 33.6 | 34.6 |
| RDW-CV [%] | 12.9 | 14.9 | 13 | 13 | 14.1 | 13.8 |
| PLT [10−15 /μl] | 310 | 365 | 181 | 228 | 305 | 322 |
| MPV [10−15 /μl] | 11 | 11 | 12.7 | 12.9 | 10.6 | 10.9 |
| AspAT [U/l] | 87 | 64 | ||||
| AlAT [U/l] | 109 | 97 | ||||
| CRP [mg/l] | 89.5 | 8.13 | 73.2 | 131 | 19.1 | 21.4 |
| CK [U/l] | 1144 | |||||